Digital healthcare company Humanscape announced that it has completed a bridge round of funding, following its Series C round, valued at 5 billion won. The company plans to use this investment to strengthen its financial foundation for executing its growth strategy and pursuing an IPO ahead of its IPO.
Naver participated as a new investor in this round, along with existing investors Korea Investment Partners Singapore and Daewoong Investment, an affiliate of Daewoong Pharmaceutical. Korea Investment Partners has invested in Humanscape three times, maintaining a long-term partnership.
Humanscape operates Mamitok, a pregnancy and childcare platform, and Rarenote, a patient data-driven platform. Mamitok, which works with obstetrics and gynecology clinics to provide ultrasound imaging, AI-based growth analysis, and information related to pregnancy, childbirth, and childcare, has established itself as a leading pregnancy and childcare platform in Korea. Overseas, user growth has been particularly strong in the US, Vietnam, and Indonesia, with global revenue more than tripling year-over-year.
RareNote is a platform that provides patients with personalized information, including medical record management, treatment cost calculations, and medication management. The patient data accumulated in the rare disease field will serve as a foundation for future global clinical research and treatment development.
Humanscape plans to use this investment to expand its global market, focusing on the United States, research and development of AI healthcare solutions utilizing patient and platform data, and advancement of AI-based services.
Meanwhile, Humanscape signed a contract with KB Securities as the lead underwriter for its KOSDAQ listing last September and is currently preparing for its listing. This investment brings the company's cumulative investment to 80 billion won.
Jang Min-hu, CEO of Humanscape, stated that with this investment, the company plans to strengthen its competitiveness in the global market based on the achievements it has made in Korea.
- See more related articles
You must be logged in to post a comment.